Alnylam Announces Appointment of Elliott Sigal, M.D., Ph.D., to Board of Directors
– Dr. Sigal Brings Decades of Leadership Experience at Biopharmaceutical Companies – – Served as Chief Scientific Officer and a Director of Bristol-Myers Squibb – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) the leading RNAi therapeutics company, announced today the appointment of Elliott Sigal, M.D., Ph.D., to its Board of Directors. Dr. Sigal brings decades … [Read more…]
